Gene expression profiling test system for breast cancer prognosis tests
- Level
- Commodity
- Parent
- 41181900
- Below
- 0
- Links · KBLI
- 4
Definition
UNSPSC 41181946In this classification, a Gene expression profiling test system for breast cancer prognosis tumor associated antigen immunological test system that consists of the reagents used to identify by immunochemical techniques Gene expression profiling test system for breast cancer prognosis based tumors. US FDA regulates Gene expression profiling test system for breast cancer prognosis under 21 CFR 866.6040and under FDA product code NYI.
Same parent
Under 41181900 · 47Activities that produce or sell this
KBLI · 4Inherited from family 41180000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.